Direct transcriptional activation of human caspase-1 by tumor suppressor p53

Area of Science:

• Molecular Biology
• Cell Biology
• Genetics

Background:

• The tumor suppressor protein p53 is a critical transcription factor involved in cellular responses.
• p53's functions are often mediated through the transcriptional activation of target genes.
• Caspase-1 (interleukin-1beta converting enzyme) is implicated in cytokine production and apoptosis.

Purpose of the Study:

• To investigate whether caspase-1 is a transcriptional target of the p53 protein.
• To elucidate the regulatory relationship between p53 and caspase-1 gene expression.

Main Methods:

• Overexpression of p53 in MCF-7 cells to assess caspase-1 mRNA levels.
• Analysis of the human caspase-1 promoter for p53-binding sites using gel shift assays.
• Reporter construct assays in HeLa and MCF-7 cells to evaluate p53-mediated promoter activity.
• Treatment with doxorubicin to induce p53 levels and assess caspase-1 gene regulation in different cell lines.

Main Results:

• Caspase-1 mRNA levels increased upon p53 overexpression.
• A functional p53-binding site was identified in the human caspase-1 promoter.
• Normal p53, but not mutant p53, activated the caspase-1 promoter reporter construct.
• Mutation of the p53-binding site abolished p53-mediated transactivation.
• Doxorubicin treatment enhanced caspase-1 promoter activity and mRNA levels in p53-positive cells, but not in p53-negative or mutant p53 cells.

Conclusions:

• Caspase-1 is a direct transcriptional target of the tumor suppressor protein p53.
• Endogenous p53 plays a significant role in regulating caspase-1 gene expression.
• This interaction provides a new link between p53-mediated tumor suppression and inflammatory/apoptotic pathways.